Healthcare Professionals

Committed to helping you meet the evolving challenges and opportunities in patient care.

Healthcare Professionals
  • Critical Care

    Providing innovative therapies and technologies to help you treat patients with life-threatening illnesses in the Intensive Care Unit.

  • Hospital Care

    From the pharmacy to the bedside, we help you increase safety, streamline processes and build cost efficiency throughout the hospital.

  • Nutritional Care

    Acute and chronic nutritional care for your patients who are unable to get adequate nutrients orally or enterally.

  • Renal Care

    Pioneering innovation in haemodialysis and peritoneal dialysis to help you achieve better outcomes for your patients.

  • Surgical Care

    Delivering innovative surgical products that help you operate with confidence, precision and speed.

  • Our Products

    Our portfolio of acute, nutritional, renal, hospital and surgical care products helps advance healthcare around the world.

Perspectives

For more than 85-years, we have worked at the intersection of saving and sustaining lives.

Perspectives
  • Patients' Stories

    Patients’ journeys inspire our work and drive our commitment.

  • Healthcare Insights

    We’re engaging with industry thought leaders to explore how science and innovation advance healthcare.

  • Community Engagement

    Enriching the communities where we live and work.

  • People of Baxter

    Our organization is enriched by a diverse population of individuals that work together to drive better healthcare options for patients around the world.

Our Story

Our more than 85-year heritage gives us distinct perspective on the needs of patients and caregivers. We lead today by putting those insights to work to deliver new, better healthcare solutions and access to care in the communities where we live and work.

Our Story
  • Our Commitment to Ireland

    Our presence in Ireland for more than 50 years

  • Our Governance

    We are proud of our strong commitment to maintaining the highest standards of corporate governance.

  • Fuelling Collaborative Innovation

    Nurturing a culture of innovation is critical to delivering on our mission to save and sustain lives. We partner with the healthcare community to continually find more efficient, smarter ways to help solve the world's most pressing healthcare challenges.

  • Corporate Responsibility

    We are committed to doing business the right way, ensuring that we champion our employees, our communities, our customers and patients, and our environment in everything we do.

  • Inclusion & Diversity

    We are committed to attracting, motivating and retaining an inclusive and diverse workforce.

Patients

Helping you reach a healthy life, full of possibility.

Patients
  • Critical Care

    When every moment counts, our therapies help healthcare professionals provide life-sustaining treatment to you or your loved ones.

  • Hospital Care

    From the pharmacy to the bedside, we support you and your healthcare providers with intravenous medications and infusion technologies designed with safety in mind.

  • Nutritional Care

    When medical conditions prevent you from adequately feeding yourself, we work with your healthcare provider to help you regain or maintain your health, through life-saving clinical nutrition options.

  • Renal Care

    Chronic kidney disease (CKD) is an ongoing journey. While every journey is unique, we are with you and your healthcare provider, every step of the way, providing options to meet your lifestyle needs.

  • Surgical Care

    We partner with surgical teams around the world so they can operate with confidence, precision and speed for a successful outcome to your surgery.

  • Empowering Patients

    We work in partnership with HSE organisations to enable you to self-care and manage your therapy at home.

Baxter Announces Partnership With Zeosys Medical to Bring Innovative, Environmentally Friendly Anaesthesia Gas Recapture Technology to Hospitals

Press Release

  • Facilitates efficient capture and recycling of anaesthetic gases

  • Helps hospitals achieve waste reduction and environmental sustainability goals

  • Versatile design integrates with existing anaesthesia systems in a variety of clinical settings

PDF

Compton, UK -

Baxter International Inc. (NYSE:BAX), a global leader in sterile medication production and delivery, today announced a definitive agreement with ZeoSys Medical to commercialise technology to capture and recycle anaesthetic gases. The agreement provides Baxter with worldwide distribution rights and an exclusive license to commercialise the technology outside of Europe, as well as an exclusive option to acquire ZeoSys Medical.

The ZeoSys Medical anaesthetic gas recapture technology consists of two components: The CONTRAfluran™ canister separates anaesthetic gas from expired air for safe capture and storage, and the SENSOfluran™ Fill Level Control Unit1 monitors canister status to signal for timely canister exchange. Both components are designed to work with existing anaesthesia machines and feature simple installation in a variety of clinical settings, including operating theatres and surgical suites.

Once canisters are full, Baxter will replace them and ship the used canisters to a specialised facility that separates the used anaesthetic from the canister. The two companies are actively completing the development and regulatory approvals to sterilise and reprocess the gas into licensed medicinal product, creating a full circular economy system for inhaled anaesthetics.

“Baxter is proud to work with hospitals to help them increase efficiency, reduce waste and minimise environmental impact,” said Andrew Goldney, vice president of Baxter’s Medication Delivery and Pharmaceuticals businesses in Europe. “Through specialised training in low-flow administration of anaesthesia, and now introducing gas recapture technology, hospitals can choose an inhaled anaesthetic based on clinical benefits that best meet both patient needs and more sustainable health care goals.”

Inhaled anaesthetics are critically important agents in performing surgical procedures for patients. Baxter is a leading manufacturer of products for general anaesthesia.

The CONTRAfluran and SENSOfluran technology is expected to be available from Baxter in the third quarter of 2020 as part of a phased launch in select European countries, with forthcoming launches in additional markets around the globe. Additional terms of the agreement were not disclosed.

  1. ZeoSys Medical GmbH. CONTRAfluran™ Instructions for Use. Luckenwalde, Germany.

About Baxter Pharmaceuticals

Baxter provides a wide range of high-value generic injectable medicines that help treat some of the most pressing healthcare needs facing patients today, including difficult-to-manufacture oncology drugs and standard-dose, ready-to-use premixed injectable anti-infectives, analgesics and critical care medicines. Baxter has rapidly expanded its pharmaceuticals portfolio through recent acquisitions, strategic partnerships and internal development programs that will help increase access to essential medicines and advance pharmacy efficiency and patient care. Baxter was the first company to offer all three of the most commonly used inhaled anaesthetics for general anaesthesia.

About Baxter

Every day, millions of patients and caregivers rely on Baxter’s leading portfolio of critical care, nutrition, renal, hospital and surgical products. For more than 85 years, we’ve been operating at the critical intersection where innovations that save and sustain lives meet the healthcare providers that make it happen. With products, technologies and therapies available in more than 100 countries, Baxter’s employees worldwide are now building upon the company’s rich heritage of medical breakthroughs to advance the next generation of transformative healthcare innovations. To learn more, visit www.baxterhealthcare.ie.

Baxter is a registered trademark of Baxter International Inc. ZeoSys Medical, CONTRAfluran and SENSOfluran are trademarks of ZeoSys Medical.